Target intelligence / Profile preview

Novel transcript, antisense to TRIM38

Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

ENSG00000272558 encodes a long non-coding RNA transcript that runs antisense to the TRIM38 locus[1][5]. Antisense lncRNAs are pervasively transcribed in mammalian genomes and function by various mechanisms, such as forming RNA-RNA duplexes, modulating splicing, regulating mRNA stability, or affecting epigenetic chromatin states[3][4]. However, there is no published evidence detailing the specific function, disease relevance, or regulatory effects for this antisense transcript in relation to TRIM38 or any biological process. It is not considered a canonical therapeutic target. This annotation is generic for genome-wide transcriptome reference and does not reflect a well-studied molecular entity, pathway, or drug target. Most information about antisense lncRNAs comes from general studies of natural antisense transcripts rather than any unique characterization for ENSG00000272558[3][4][5].

Other names
ENSG00000272558lncRNA antisense to TRIM38
02

Biological functions

Potential regulatory roles in gene expressionpossible involvement in mRNA processing, splicing regulation, epigenetic modification, or chromatin remodeling (general functions for antisense lncRNAs, not specifically shown for this transcript)
03

Disease associations

Unknown for this transcript; general antisense lncRNAs have been implicated in various disease processes (e.g., cancer, neurodegeneration), but no specific disease association for ENSG00000272558

Beyond the preview

Go deeper on Novel transcript, antisense to TRIM38.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TRIM38.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call